Phase 3 Readout~month

Phase 3 Topline: A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy

Indication
Ocular Hypertension; Cataract; Glaucoma

Other upcoming events for SGP

Phase 1 StartPhase 1 Start: Prospective, Multi-Center, Open-Label, Non-Randomized, Multi-Arm Study to Evaluate the Safety, Effic
Phase 3 ReadoutPhase 3 Topline: A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy — SGP Phase 3 Readout | BioSniper